|
Market Closed -
TEL AVIV STOCK EXCHANGE
02:24:49 27/10/26 am AEDT
|
5-day change | 1st Jan Change | ||
| 2,407.00 ILa | +0.42% |
|
+1.78% | +6.50% |
| 06/10 | Kamada Launches Ustekinumab, Enoxaparin Biosimilars in Israel | MT |
| 06/10 | Kamada Ltd. Announces Expansion of Biosimilars Portfolio with Launch of Two Additional Products in Israel | CI |
| Market Cap | 1.39B 0 450M 403M 373M 337M 631M 42.85B 642M 4.48B 1.77B 22.41B 1.69B 1.65B 70.97B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 1.39B 0 450M 403M 373M 337M 631M 42.85B 642M 4.48B 1.77B 22.41B 1.69B 1.65B 70.97B | EV / Sales 2026 * |
2.28x | EV / Sales 2027 * | 2.03x |
| Free-Float |
54.72% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
TEL AVIV STOCK EXCHANGE
| KMDA | Delayed | |
Nasdaq
| KMDA | Delayed | |
|
CBOE
| KMDA | Real-time |
Last Transcript: Kamada Ltd.
| 1 day | +0.42% | ||
| 1 week | +1.78% | ||
| Current month | -9.17% | ||
| 1 month | -9.71% | ||
| 3 months | +11.44% | ||
| 6 months | -1.51% | ||
| Current year | +6.50% |
| 1 week | 2,378 |  | 2,499 |
| 1 month | 2,300 | | 2,691 |
| Current year | 2,013 | | 2,890 |
| 1 year | 1,956 | | 2,890 |
| 3 years | 1,685 | | 3,045 |
| 5 years | 1,309 | | 3,045 |
| 10 years | 1,309 | | 4,500 |
| Manager | Title | Age | Since |
|---|---|---|---|
Amir London
CEO | Chief Executive Officer | 58 | 01/07/2015 |
Chaime Orlev
DFI | Director of Finance/CFO | 56 | 31/12/2017 |
Eran Nir
COO | Chief Operating Officer | 54 | 01/11/2016 |
| Director | Title | Age | Since |
|---|---|---|---|
David Tsur
BRD | Director/Board Member | 75 | 13/12/1990 |
Leon Recanati
CHM | Chairman | 77 | 07/03/2013 |
| Chairman | 55 | 12/08/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 14/9/26 | Exercice | VP Quality | 61,323 | 0.1063% | ||
| 14/9/26 | Sell | Founder | -22,827 | 0.0396% | ||
| 14/9/26 | Exercice | General Counsel | 23,459 | 0.0407% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.42% | +1.78% | +6.46% | +39.70% | 450M | |
| +0.34% | -0.12% | +55.14% | +128.86% | 1,140B | |
| +0.35% | +3.05% | +40.44% | +83.56% | 641B | |
| -0.15% | -0.85% | +25.69% | +106.30% | 507B | |
| +0.63% | +2.33% | +49.21% | +67.82% | 383B | |
| +1.00% | -4.13% | +61.56% | +38.27% | 347B | |
| +1.02% | +1.80% | +24.84% | +53.75% | 293B | |
| -0.25% | +1.62% | +2.20% | +26.65% | 266B | |
| +0.64% | +2.01% | +53.79% | +71.18% | 240B | |
| -0.51% | +0.93% | +31.12% | +106.16% | 197B | |
| Average | +0.32% | +2.81% | +35.04% | +72.23% | 401.43B | |
| Weighted average by Cap. | +0.32% | +2.98% | +42.08% | +88.30% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 609M 0 197M 176M 163M 148M 277M 18.77B 281M 1.96B 777M 9.82B 741M 725M 31.09B | 685M 0 222M 199M 184M 166M 312M 21.15B 317M 2.21B 875M 11.06B 834M 816M 35.02B |
| Net income | 83.39M 0 27.04M 24.18M 22.37M 20.25M 37.91M 2.57B 38.53M 269M 106M 1.35B 101M 99.32M 4.26B | 101M 0 32.85M 29.38M 27.18M 24.61M 46.06M 3.13B 46.81M 327M 129M 1.63B 123M 121M 5.18B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/10/26 | ILA 2,407.00 | +0.42% | 23,000 |
| 23/10/26 | ILA 2,397.00 | -0.83% | 12,597 |
| 22/10/26 | ILA 2,417.00 | -0.21% | 22,152 |
| 21/10/26 | ILA 2,422.00 | -0.41% | 43,458 |
| 20/10/26 | ILA 2,432.00 | +2.83% | 47,991 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- KMDA Stock
Select your edition
All financial news and data tailored to specific country editions
